🚀 VC round data is live in beta, check it out!
aap Implantate Valuation Multiples
Discover revenue and EBITDA valuation multiples for aap Implantate and similar public comparables like Modular Medical, Harvard Bioscience, Finemedix, Lifeward and more.
aap Implantate Overview
About aap Implantate
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
Founded
1997
HQ
Employees
109
Website
Sectors
Financials (FY)
EV
$27M
aap Implantate Financials
aap Implantate reported last fiscal year revenue of $14M and negative EBITDA of ($1M).
In the same fiscal year, aap Implantate generated $13M in gross profit, ($1M) in EBITDA losses, and had net loss of ($4M).
Revenue (LTM)
aap Implantate P&L
In the most recent fiscal year, aap Implantate reported revenue of $14M and EBITDA of ($1M).
aap Implantate expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $14M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 87% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (10%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (22%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (30%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
aap Implantate Stock Performance
aap Implantate has current market cap of $27M, and enterprise value of $27M.
Market Cap Evolution
aap Implantate's stock price is $1.85.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $27M | $27M | 0.0% | XXX | XXX | XXX | $-0.29 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Trialaap Implantate Valuation Multiples
aap Implantate trades at 1.9x EV/Revenue multiple, and (18.9x) EV/EBITDA.
EV / Revenue (LTM)
aap Implantate Financial Valuation Multiples
As of April 20, 2026, aap Implantate has market cap of $27M and EV of $27M.
Equity research analysts estimate aap Implantate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
aap Implantate has a P/E ratio of (6.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $27M | XXX | $27M | XXX | XXX | XXX |
| EV (current) | $27M | XXX | $27M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (18.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (8.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.1x | XXX | XXX | XXX |
| P/E | — | XXX | (6.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (15.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified aap Implantate Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
aap Implantate Margins & Growth Rates
aap Implantate's revenue in the last fiscal year grew by 6%.
aap Implantate's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
aap Implantate Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (65%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 25% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 110% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
aap Implantate Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| aap Implantate | XXX | XXX | XXX | XXX | XXX | XXX |
| Modular Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Finemedix | XXX | XXX | XXX | XXX | XXX | XXX |
| Lifeward | XXX | XXX | XXX | XXX | XXX | XXX |
| Icecure Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
aap Implantate M&A Activity
aap Implantate acquired XXX companies to date.
Last acquisition by aap Implantate was on XXXXXXXX, XXXXX. aap Implantate acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by aap Implantate
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free Trialaap Implantate Investment Activity
aap Implantate invested in XXX companies to date.
aap Implantate made its latest investment on XXXXXXXX, XXXXX. aap Implantate invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by aap Implantate
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout aap Implantate
| When was aap Implantate founded? | aap Implantate was founded in 1997. |
| Where is aap Implantate headquartered? | aap Implantate is headquartered in Germany. |
| How many employees does aap Implantate have? | As of today, aap Implantate has over 109 employees. |
| Is aap Implantate publicly listed? | Yes, aap Implantate is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of aap Implantate? | aap Implantate trades under AAQ1 ticker. |
| When did aap Implantate go public? | aap Implantate went public in 1999. |
| Who are competitors of aap Implantate? | aap Implantate main competitors are Modular Medical, Harvard Bioscience, Finemedix, Lifeward. |
| What is the current market cap of aap Implantate? | aap Implantate's current market cap is $27M. |
| What is the current revenue of aap Implantate? | aap Implantate's last fiscal year revenue is $14M. |
| What is the current EV/Revenue multiple of aap Implantate? | Current revenue multiple of aap Implantate is 1.9x. |
| Is aap Implantate profitable? | No, aap Implantate is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.